IL322860A - Material, diagnostic marker for gastric cancer, method for detecting enzymatic activity, kit containing the material, and method for treating gastric cancer - Google Patents

Material, diagnostic marker for gastric cancer, method for detecting enzymatic activity, kit containing the material, and method for treating gastric cancer

Info

Publication number
IL322860A
IL322860A IL322860A IL32286025A IL322860A IL 322860 A IL322860 A IL 322860A IL 322860 A IL322860 A IL 322860A IL 32286025 A IL32286025 A IL 32286025A IL 322860 A IL322860 A IL 322860A
Authority
IL
Israel
Prior art keywords
gly
thr
compound
formula
abz
Prior art date
Application number
IL322860A
Other languages
English (en)
Hebrew (he)
Inventor
LESNER Adam
GRUBA Natalia
Original Assignee
Urteste S A
LESNER Adam
GRUBA Natalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urteste S A, LESNER Adam, GRUBA Natalia filed Critical Urteste S A
Publication of IL322860A publication Critical patent/IL322860A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL322860A 2023-02-21 2024-02-19 Material, diagnostic marker for gastric cancer, method for detecting enzymatic activity, kit containing the material, and method for treating gastric cancer IL322860A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL443839A PL443839A1 (pl) 2023-02-21 2023-02-21 Związek, marker diagnostyczny raka żołądka, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka żołądka, zestaw zawierający taki związek oraz zastosowania takiego związku i sposób leczenia raka żołądka
PCT/PL2024/050014 WO2024177524A1 (en) 2023-02-21 2024-02-19 Compound, diagnostic marker for stomach cancer, method for detecting enzymatic activity, method for the diagnosis of stomach cancer, kit comprising the compound, uses of the compound and method for the treatment of stomach cancer

Publications (1)

Publication Number Publication Date
IL322860A true IL322860A (en) 2025-10-01

Family

ID=90719853

Family Applications (1)

Application Number Title Priority Date Filing Date
IL322860A IL322860A (en) 2023-02-21 2024-02-19 Material, diagnostic marker for gastric cancer, method for detecting enzymatic activity, kit containing the material, and method for treating gastric cancer

Country Status (9)

Country Link
EP (1) EP4669964A1 (pl)
JP (1) JP2026506172A (pl)
KR (1) KR20250143356A (pl)
CN (1) CN120769986A (pl)
AU (1) AU2024226118A1 (pl)
IL (1) IL322860A (pl)
MX (1) MX2025009077A (pl)
PL (1) PL443839A1 (pl)
WO (1) WO2024177524A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101016213B1 (ko) * 2007-11-20 2011-02-25 한국과학기술연구원 단백질 분해효소의 영상화를 위한 소광된 형광 센서, 그제조 방법 및 용도
KR20110039093A (ko) * 2009-10-09 2011-04-15 한국과학기술연구원 단백질 분해효소 활성 측정용 시험관내 키트 및 그 제조방법
EP3919911A1 (en) * 2020-06-04 2021-12-08 Urteste S.A. Novel diagnostic marker for prostate cancer

Also Published As

Publication number Publication date
KR20250143356A (ko) 2025-10-01
PL443839A1 (pl) 2024-08-26
MX2025009077A (es) 2025-09-02
WO2024177524A1 (en) 2024-08-29
JP2026506172A (ja) 2026-02-20
EP4669964A1 (en) 2025-12-31
CN120769986A (zh) 2025-10-10
AU2024226118A1 (en) 2025-08-21

Similar Documents

Publication Publication Date Title
US20240353410A1 (en) Fret enzymatic substrate and uses thereof in liver cancer
IL322860A (en) Material, diagnostic marker for gastric cancer, method for detecting enzymatic activity, kit containing the material, and method for treating gastric cancer
US20250376711A1 (en) Compound-diagnostic marker for uterine body cancer, method for detecting enzymatic activity, method for diagnosis of uterine body cancer, kit comprising the compound, uses of the compound and method for the treatment of uterine body cancer
US20260098058A1 (en) Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancer
IL321972A (en) Composition, diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosing biliary tract cancer, kit containing the composition, uses of the composition and method for treating biliary tract cancer
US20250206777A1 (en) Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancer
US20250003970A1 (en) Fret enzymatic substrate and uses thereof in lung cancer
WO2023204721A1 (en) Compound - diagnostic marker for kidney cancer, method lor detecting enzymaticactivity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancer
WO2025005815A1 (en) Compound, diagnostic marker for breast cancer, method for detecting enzymatic activity, method for the diagnosis of breast cancer, kit comprising the compound, uses of the compound and method for the treatment of breast cancer
HK40116114A (zh) 化合物-子宫体癌诊断标志物、检测酶活性的方法、诊断子宫体癌的方法、含该化合物的试剂盒、该化合物的用途和治疗子宫体癌的方法